Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Breast Cancer
100%
Chromosomal Instability
81%
Pesticides
54%
Clonal Heterogeneity
54%
Colombian
54%
Transcriptome Analysis
54%
Exosomes
49%
Androgen Receptor
40%
Chromosomal Alterations
40%
MicroRNA
36%
Non-coding RNA (ncRNA)
31%
Breast Cancer Cells
29%
RNA Interaction
27%
Obesity Receptor
27%
Androgen Receptor Gene
27%
Primary Breast Cancer
27%
Intrinsic Subtype
27%
Adipokines
27%
Bioinformatics Tools
27%
Gene Expression
27%
Meta-analysis
27%
Androgen Signaling
27%
Biomarkers of Effect
27%
Biomarkers of Susceptibility
27%
Organic Solvents
27%
Car Painters
27%
Integrative Network Analysis
27%
Exosomal miRNA
27%
Non-clonal
27%
Non-clonal Chromosome Aberrations
27%
Overcoming Resistance
27%
Exposure to Asbestos
27%
Germline BRCA1/2 mutation
27%
Tumor Cells
27%
Biological Characteristics
27%
Primary Breast Angiosarcoma
27%
Antitumor Immune Response
27%
Cancer Patients
27%
African Ancestry
27%
Breast Cancer Cell Lines
27%
Early Onset
27%
Asbestos
27%
Immune Cells
27%
Molecular Genomics
27%
Circulating Blood
27%
High Prevalence
27%
Therapy Response
27%
Molecular Characteristics
27%
Resistance Resistance
27%
Genetic Damage
27%
Exposure to Pesticides
23%
BRCA2
23%
Obesity
20%
Angiosarcoma
18%
Molecular Mechanism
17%
Occupational Exposure
16%
Breast Cancer Patients
16%
Micronucleated Cells
16%
CYP2E1 Polymorphism
16%
Micronucleus
16%
Estrogen Receptor
15%
Breast Cancer Subtypes
14%
Exposed Groups
14%
Patients with Breast Cancer
14%
Androgens
13%
Afro-Colombian
13%
Lung Cancer
13%
Pulmonary Disease
13%
Clinical Problems
12%
In Cancer
11%
Poor Prognosis
11%
Basal-like
10%
Nucleoplasmic Bridge
10%
Genotype
10%
Intraluminal Vesicles
10%
Statistically Significant Difference
10%
Clinical Parameters
10%
Late Endosome
10%
Cancer Development
10%
Resistance to Treatment
10%
Mestizo
10%
Docetaxel
9%
Herceptin
9%
Nucleic Acids
9%
Cancer Cells
9%
Exposure to Radiation
9%
Rare Pathology
9%
FLI1
9%
Healthy Tissue
9%
Neoplasms
9%
Lymphedema
9%
Neoplastic Tissue
9%
Transcriptome Studies
9%
White Women
9%
Family Cancer History
9%
CD34
9%
CD31
9%
Public Database
9%
Healthy Individuals
9%
Differential Diagnosis
9%
Biochemistry, Genetics and Molecular Biology
Chromosome Instability
81%
Non-Coding RNA
54%
Prevalence
54%
Gene Expression
31%
Cancer Cell
27%
Androgen Receptor
27%
MicroRNA
27%
BRCA1
27%
Bioinformatics
27%
Gene Expression Profiling
27%
Transcriptome
27%
Receptor Gene
27%
CYP2E1
27%
Germline Mutation
27%
Prognostic Biomarker
27%
Diagnostic Biomarker
27%
Cytogenetics
16%
Estrogen Receptor
16%
Messenger RNA
15%
Genotyping
13%
Peripheral Blood Lymphocyte
13%
Somatic Cell
12%
Chromosome Variant
10%
Fluorescence in Situ Hybridization
10%
Trastuzumab
9%
Doxorubicin
9%
Chromosome
7%
Monosomy
6%
Lymphocyte
6%
Allele
6%
Cross Sectional Study
6%
Chromosome Analysis
6%
Awareness
5%